Pharmacy groups’ motion for preliminary injunction denied in Medco-Express Scripts case
U.S. District Judge Cathy Bissoon has denied a motion for preliminary injunction raised by retail pharmacy groups challenging Express Scripts’ purchase of Medco Health Solutions. Judge Bissoon found that plaintiffs were unable to show the likelihood of immediate, irreparable harm. The harm that they did allege–displaced management and the exchange of confidential information and trade secrets between Medco and Express Scripts–was found to have already happened because of the two companies’ integration plan of July 2011. Morever, Judge Bissoon found that a temporary injunction would render Medco unable to compete with Express Scripts, as nearly all of Medco’s senior management has already been terminated.
Featured News
New York Puts Businesses on Notice for Algorithmic Pricing
Mar 19, 2026 by
CPI
Herbert Smith Freehills Kramer Expands US Antitrust Team with New Partner Hire
Mar 19, 2026 by
CPI
Mexico Antitrust Authority Fines Oxygen Suppliers Over Exclusive Contracts
Mar 19, 2026 by
CPI
EU Cloud Group Pushes for Halt to Broadcom VMware Changes
Mar 19, 2026 by
CPI
Sen. Blackburn Releases Discussion Draft of Bill to Set Federal ‘Framework’ for AI Policy
Mar 19, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Data-Driven Competition
Mar 19, 2026 by
CPI
Data-Driven Competition: Implications For Enforcement and Merger Control
Mar 19, 2026 by
Alexandre de Corniere & Greg Taylor
From Tipping to Trustees: Why Data-Driven Markets Require Institutional Design, Not Optimization
Mar 19, 2026 by
Jens Prüfer & Paul de Bijl
Data Barriers to Entry: What We’ve Learned About Spotting Them and What We Still Don’t Know About Solutions
Mar 19, 2026 by
Bruno Carballa-Smichowski
When the Perfect Is the Enemy of the Good: Price Discrimination, Affordability, Precarity and Market Dynamism
Mar 19, 2026 by
Dan Ciuriak